Therapeutic patient education in children with moderate to severe atopic dermatitis: A multicenter randomized controlled trial in China

Publisher： John Wiley & Sons Inc

E-ISSN： 1525-1470|35|1|70-75

ISSN： 0736-8046

Source： PEDIATRIC DERMATOLOGY, Vol.35, Iss.1, 2018-01, pp. : 70-75

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunologic Effects of Omalizumab in Children with Severe Refractory Atopic Dermatitis: A Randomized, Placebo-Controlled Clinical Trial

By  

International Archives of Allergy and Immunology, Vol. 162, Iss. 1, 2013-06 ,pp. : 89-93

Karger

Access to resources Recommend Favorite

Dupilumab treatment improves quality of life in adult patients with moderate‐to‐severe atopic dermatitis: results from a randomized, placebo‐controlled clinical trial

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : 406-414

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dupilumab treatment improves quality of life in adult patients with moderate‐to‐severe atopic dermatitis: results from a randomized, placebo‐controlled clinical trial

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : e168-e168

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effectiveness of alpine climate treatment for children with difficult to treat atopic dermatitis: Results of a pragmatic randomized controlled trial (DAVOS trial)

By  

CLINICAL & EXPERIMENTAL ALLERGY, Vol. 48, Iss. 2, 2018-02 ,pp. : 186-195

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Multimodal Education and Treatment Program for Young Adults with Atopic Dermatitis: A Randomized Controlled Trial

By  

Dermatology and Psychosomatics / Dermatologie und Psychosomatik, Vol. 1, Iss. 4, 2001-01 ,pp. : 148-153

Karger

Access to resources Recommend Favorite